Found 0 matching trials
480 STUDY: Phase 2b Study of Locteron Plus Ribavirin to Treat Hepatitis C Virus (HCV) PHASE2 The purpose of this 12-week study was to assess in subjects with chronic he...
Show More Learn More & Join Trial
The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg PHASE4 As HBsAg clearance is uncommon in chronic hepatitis B (CHB) patients on nuc...
Show More Location
The third affiliated hospital of Sun Yat-sen University
Learn More & Join Trial
Evaluation of Hepatic Pharmacokinetics for Grazoprevir (MK-5172) in Participants With Chronic Hepatitis C (MK-5172-022) PHASE1 This study is divided into 2 segments, and proposes to qualify fine needle ...
Show More Location
Multiple Locations
Learn More & Join Trial
Pegylated Interferon (PEG-IFN) Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight (Study P05172)(COMPLETED) PHASE4 The objective is to evaluate the efficacy and safety of the combination the...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Boceprevir in Asia Pacific Participants With Chronic Hepatitis C Genotype 1 (P07063) PHASE3 This study will assess the efficacy of boceprevir (BOC) in combination with...
Show More Location
Multiple Locations
Learn More & Join Trial
Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085) PHASE3 This study aims to compare the role of peginterferon α-2b (50 μg/week) vs. ...
Show More Location
Multiple Locations
Learn More & Join Trial
PROPHESYS 3: Observational Study on Predictors of Response in Patients With Treatment-naïve Chronic Hepatitis C Initiated on Treatment With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b N/A This observational study will assess predictors of early on-treatment and s...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116) PHASE3 The objective is to evaluate the efficacy and safety of combination therapy...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera Patients PHASE3 Polycythemia Vera (PV) is a disease of bone marrow stem cells that manifest...
Show More Learn More & Join Trial
PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma PHASE2 RATIONALE: Peginterferon (PEG-interferon) alfa-2b may stop the growth of ca...
Show More Location
UAB Comprehensive Cancer Center
Learn More & Join Trial